Walmart and TJX are seen as particularly savvy in navigating an economy of haves and have-nots headed into the holidays.

Ascendis Pharma’s consensus analyst price target has recently increased from $245.61 to $258.77 per share. This reflects a renewed sense of optimism as Yorvipath’s uptake accelerates and real-world ...

The PlayStation Portal has become a lot more useful now that it has full access to Sony's cloud gaming library.